Leukaemia diagnosis and management (Diagnosis and management of leukaemia)

What is leukaemia diagnosis and management?

Leukaemia is a cancer of the blood-forming cells, usually starting in the bone marrow where blood cells are made. In leukaemia, abnormal white cells build up and crowd out normal blood cells, which can cause tiredness, infections, bruising and bleeding.

Diagnosis and management means finding out whether someone has leukaemia, identifying the exact type, and then planning care. The exact type matters enormously, because leukaemias behave very differently and are treated very differently.

There are four main types. Acute leukaemias — acute myeloid leukaemia (AML) and acute lymphoblastic leukaemia (ALL) — develop quickly and usually need urgent treatment, often starting with intensive chemotherapy. Chronic leukaemias — chronic lymphocytic leukaemia (CLL) and chronic myeloid leukaemia (CML) — develop more slowly; some people with CLL are monitored for years without treatment, and CML is often well controlled with daily targeted tablets.

This guide explains the general pathway. It cannot tell you your outlook, because that depends on the precise type, the genetic features of the leukaemia, your age and your health. Some leukaemias can be cured or put into long-lasting remission, while for others treatment aims to control the disease and keep you well rather than cure it. Care is always led by a specialist blood-cancer team (a multidisciplinary team, or MDT), and your team will explain what treatment is aiming to achieve in your case.

Types, options & approaches

There may be different ways to do this. The right approach depends on the clinical question and your circumstances.

Acute versus chronic leukaemia

This is a general picture only. Your exact type and its genetic features decide the real plan and what treatment is aiming to achieve.

Preparing for your treatment

• Bring all your blood results and any previous counts, so changes can be seen.
• Write down your symptoms and when they started, such as tiredness, infections, bruising, bleeding, night sweats or weight loss.
• List all medicines and supplements, and any other health conditions, as these affect treatment choices.
• Bring a list of questions, and consider bringing someone with you, as a lot of information is discussed.
• Ask whether you should expect a bone marrow test, and what it involves.
• If treatment may affect fertility, ask about this before it starts, as options may need to be arranged early.
• Make sure your specialist team and GP can share information, especially if any care is private.
• Ask how urgently decisions need to be made, as acute types move quickly.

What happens

Diagnosis usually begins with blood tests, including a full blood count and a blood film, often prompted by abnormal counts or symptoms. If leukaemia is suspected, you are referred urgently to a haematology team.

The key test is usually a bone marrow sample, taken under local anaesthetic (sometimes with sedation), where the abnormal cells are made. The sample is examined under the microscope and undergoes specialist genetic and molecular tests. These tests confirm the diagnosis, pin down the exact type, and reveal features that guide treatment and outlook. Scans may be used to look for any spread or complications.

Your case is then discussed by a specialist blood-cancer team (MDT). For acute leukaemia, treatment often needs to start quickly, sometimes within days, usually with chemotherapy and supportive care. For chronic leukaemia, the team may recommend active monitoring, daily targeted tablets, or other treatment depending on the type and how active the disease is. Throughout, you should be told what the treatment is aiming to achieve and what to expect.

Is this treatment right for me?

A good consultation should explore whether it's the right choice for you now — including reasons to wait or consider something else.

Before you decide

Use this as a shared-decision checklist. The aim is not just “can this be done?”, but whether it is right for you, now, with the risks and alternatives clearly understood.

Leukaemia and its treatments carry serious risks that differ greatly by type and intensity. The most important things to discuss are what your treatment is aiming for (cure, long-term control or symptom relief), the specific risks of your plan, and the signs of infection or bleeding that need urgent attention. Be very wary of anyone offering a 'miracle cure' or guaranteeing an outcome — leukaemia care is led by specialist teams using evidence-based treatment, and no responsible clinician promises a cure.

Published figures to discuss

Outcomes in leukaemia vary so much by exact type, genetic features, age and health that quoting a single survival or response figure would be misleading and potentially distressing. Some leukaemias have high cure rates; others are controlled rather than cured. Reputable sources such as Blood Cancer UK and Cancer Research UK publish type-specific information, and even then the figures vary by person. We therefore do not state percentages here; your specialist team can give realistic, individual information, always describing what treatment aims to do rather than guaranteeing it.

These are literature figures, not a personalised prediction. Your own risks and likely benefits depend on your circumstances, your health, and how your care is carried out and followed up.

What happens afterwards

Here, 'recovery' means how diagnosis and treatment unfold and how your body and life respond, rather than recovery from a single operation. It varies enormously — from years of simple monitoring in some chronic types to months of intensive treatment in acute types.

• Tiredness during and after treatment that can take time to improve
• Repeated blood tests and clinic visits to track counts and response
• Periods of low immunity during chemotherapy, needing care to avoid infection
• Side effects from targeted tablets that are monitored and managed
• A strong emotional impact, for which support is part of good care

Aftercare

• Attend all blood tests and reviews so your counts and response are tracked closely.
• Take any targeted tablets exactly as prescribed and never stop them without advice.
• Watch for signs of infection, such as fever, and follow your team's urgent-contact advice.
• Watch for unusual bruising or bleeding and report it promptly.
• Look after general health: vaccinations as advised, dental care, and avoiding infection risks during low-immunity periods.
• Ask for, and accept, emotional and practical support, including from blood-cancer charities.
• Keep your GP and specialist team informed, and ensure any private care is shared with your NHS team.
• Ask what your follow-up plan is and what signs of relapse to watch for.

• All blood results and previous counts gathered
• List of medicines, supplements and other conditions
• Questions written down, and someone to come with you
• Understanding of what the treatment is aiming to achieve
• Urgent-contact number for fever or bleeding saved
• Fertility discussion before treatment if relevant
• GP and specialist details so information is shared

⚠ Get urgent help if…

• A high temperature, shivering or feeling very unwell (possible serious infection during treatment) — seek urgent help
• Bleeding that will not stop, or a rash of tiny red or purple spots that do not fade on pressing
• Severe breathlessness, chest pain or fainting
• Sudden severe headache, weakness, confusion or a seizure
• Vomiting blood, or black or bloody stools
• A new or rapidly enlarging lump, severe night sweats or fast weight loss
• Any symptom your team asked you to report urgently

Who to contact: your clinician, clinic or test provider first (keep their number to hand). For urgent advice when you can't reach them, call NHS 111. In an emergency, call 999.

General guidance — it doesn't replace the specific advice your specialist gives you.

Results & realistic expectations

A good result depends on the type of leukaemia and what treatment is aiming for. For some leukaemias, treatment can achieve remission (no detectable disease) and, for certain types, a cure. For others, the aim is to control the disease and keep you well for as long as possible, which is a valuable outcome in its own right.

Response is measured by repeat blood and bone marrow tests, not by how you feel alone. Remission does not always mean cure, and your team will explain what your results mean and how closely you need to be watched. Honest, specialist-led information matters more than any single number, and outlook varies by type, genetics, age and health.

How long the benefit of treatment lasts varies widely. Some people are cured; some stay in long remission; some need ongoing or repeated treatment; and some have a disease that is controlled rather than cured. Chronic myeloid leukaemia, for example, is often controlled for many years with daily tablets. Because outlook depends so heavily on the exact type and its genetics, your specialist team is the right source for what is realistic in your case.

Related tests, treatments or support

Leukaemia care often combines several elements: chemotherapy or targeted treatment, supportive care (such as transfusions and infection treatment), and sometimes radiotherapy or a stem cell transplant. Genetic and molecular testing is combined with standard tests to guide the plan. Care is coordinated by the MDT, often alongside clinical trials.

Follow-up & long-term care

Follow-up is lifelong for most people, whether on active monitoring, during treatment, or after reaching remission. You should have regular blood tests and reviews, a clear plan for what to watch for, and a named team to contact. If you reach remission, follow-up continues to check for relapse and to manage any late effects of treatment.

• Regular blood tests and reviews to monitor the disease or the response to treatment
• Continuing long-term targeted tablets where these control the leukaemia
• Monitoring for and managing late effects of treatment
• Vaccinations and infection precautions as advised by your team
• Watching for signs of relapse and knowing who to contact
• Ongoing emotional and practical support

Repeat, follow-on and what comes next

• Treatment is changed if the leukaemia does not respond well enough or if side effects are a problem.
• Chronic types on monitoring move to active treatment if and when the disease becomes more active.
• Targeted tablets may be switched if resistance develops or they are not tolerated.
• Relapse after remission may mean further treatment, which can include a transplant in some cases.

Ask what happens if the result is unclear or needs repeating, and what is included if further tests or follow-up are needed.

What good aftercare looks like

• Care led by a specialist blood-cancer multidisciplinary team, with a clinical nurse specialist as a contact.
• Clear written information on what treatment is aiming for and its risks.
• A 24-hour urgent-contact route for fever, infection or bleeding during treatment.
• Regular monitoring of the disease and of late effects, with a relapse plan.
• Coordination with the NHS, results shared with your GP, and access to emotional and practical support.

What affects the cost

Costs vary a great deal between people and providers, and we don't publish prices. What matters is understanding what drives the cost and making sure your quote is complete. The main things that affect it:

• Specialist haematology consultations and multidisciplinary team review
• Blood tests, a bone marrow test, and specialist genetic and molecular testing
• Scans used in diagnosis or to assess complications
• The treatment itself, which ranges from monitoring to chemotherapy, targeted tablets or transplant
• Supportive care, such as transfusions and treatment of infections
• Repeat tests to monitor the disease and the response over time
• Long-term follow-up and management of any late effects

• Which consultations, tests and the bone marrow test are included
• Whether specialist genetic and molecular testing is covered
• How treatment, supportive care and any hospital stays would be arranged and charged
• Whether care is coordinated with an NHS specialist blood-cancer centre
• Follow-up arrangements and a named contact for urgent problems
• Whether results and the plan are shared with your NHS GP and team
• What happens, and what it costs, if the leukaemia relapses or a complication occurs

On the NHS? Diagnosis and treatment of leukaemia are core NHS specialist care, including urgent pathways for acute types; private care is mainly used for speed, choice or a second opinion, and should be closely coordinated with your NHS team.

You're entitled to your total cost in writing — including reports, follow-up and what happens if the result is inconclusive — before you decide.

Consent traps and marketing red flags

These are not small details. They are often where patients lose choice, time to reflect, or realistic expectations.

Choosing a specialist safely

• Check the specialist is on the GMC Specialist Register for this area.
• Make sure they work at a CQC-registered service, and look for membership of the relevant Royal College or professional body.
• You're entitled to time to consider and to have your questions answered before you agree — the specialist who looks after you should explain it, not a salesperson.
• Be wary of pressure: time-limited offers or deposits taken before you've had time to think are red flags, not bargains.
• You're entitled to your total cost in writing — including any follow-up — before you decide.

How Vuemedics verifies every consultant →

Take this to your consultation. A good specialist will welcome every one of these.

• Exactly which type of leukaemia do I have, and what do its genetic features mean?
• Is my treatment aiming to cure the leukaemia, to control it, or to relieve symptoms?
• Should I start treatment now, or is monitoring safe for me?
• What are the main risks and side effects of my treatment plan?
• Could a clinical trial be suitable for me?
• What signs of infection, bleeding or relapse should I watch for, and who do I contact urgently?
• Are you on the GMC Specialist Register for this area, and which Royal College or professional body are you a member of?
• Will you be the specialist who carries out my treatment, and who looks after me afterwards?
• What are the risks for someone like me, and how often do your own patients have a problem or need it repeated or redone?
• What does a realistic result look like — and what can this treatment not achieve?
• What are my options, including waiting, doing nothing for now, or choosing a different approach?
• Can I have written information, results and aftercare instructions in a format I can use, including any accessibility or communication support I need?
• What is the total cost in writing, including any follow-ups, and how much time do I have to decide?

Find a verified specialist for leukaemia diagnosis and management

Every consultant is GMC-checked and independently reviewed. Search by postcode and distance, or switch to a map. Ordered by rating, relevance and recency — never by who pays.

How we made this page

Medically reviewed by a GMC-registered consultant. Written in plain English, checked against NHS, NICE, GMC and relevant Royal College / specialist-society guidance, and kept under review. No clinic paid to appear on this page, and we publish no pricing. This is general information to help you prepare — it is not a substitute for advice from your own clinician. How we review our guides →

Source hierarchy: UK regulator and NHS/NICE guidance first, then relevant Royal College or specialist-society guidance, then peer-reviewed evidence for procedure-specific figures where available.

Sources & standards: NHS — Leukaemia (overview and types) Blood Cancer UK — Leukaemia Macmillan Cancer Support — Leukaemia Cancer Research UK — Leukaemia Leukaemia Care — patient information British Society for Haematology — guidelines

Reviews reflect patients' experience of care, not clinical outcomes. For procedure volumes and outcome data see PHIN.

Last medically reviewed 2026-09-21. Spotted something wrong or out of date? Report an error in this guide.